DOCK3 encodes the dedicator of cytokinesis 3 protein, a member of the DOCK180 family of proteins that are characterized by guanine-nucleotide exchange factor activity. DOCK3 is expressed exclusively in the central nervous system and plays an important role in axonal outgrowth and cytoskeleton reorganization. Dock3 knockout mice exhibit motor deficiencies with abnormal ataxic gait and impaired learning. We report 2 siblings with biallelic loss-of-function variants in DOCK3. Diagnostic whole-exome sequencing (WES) and chromosomal microarray were performed on a proband with severe developmental disability, hypotonia, and ataxic gait.
| INTRODUCTION
Neurodevelopmental disabilities are clinically and genetically heterogeneous disorders, with an estimated prevalence of approximately 1%. 1, 2 In particular, severe intellectual disability is believed to be caused largely by genetic factors and affects an estimated 0.5% of the population. 3 However, identification of the underlying molecular etiology remains challenging in individual patients due to significant genetic heterogeneity, with over 1500 genes implicated in intellectual disability. [3] [4] [5] [6] The introduction of whole-exome sequencing (WES) in clinical practice in 2011 has significantly accelerated the pace of gene identification in patients with neurodevelopmental disabilities. 5, 7 This technology has allowed many patients with neurodevelopmental disorders who had previously undergone a battery of invasive, expensive, and uninformative tests to ultimately receive a definitive diagnosis. 8, 9 The DOCK3 gene (NM_004947) is located on chromosome 3p21. 3 | RESULTS
| Clinical summary
The 2 affected siblings were born to non-consanguineous Ashkenazi and Yemeni Jewish parents. Five additional siblings and the parents were unaffected ( Figure 1A ). The proband is a female patient who was born post-mature at 42 weeks. Her early development was significantly delayed; she first walked at the age of 5 years and had an unsteady gait. Neuropsychological evaluation at age 14 months was performed using "Preschool Language Scale 4" and concluded that the patient was functioning at age equivalent less than 9 months, consistent with global developmental delay. At her last visit at age 12 years, she needed support while walking and had a crouched, ataxic gait. The neurological examination revealed mildly decreased deep tendon reflexes and muscular hypotonia. She was non-verbal and was not toilet trained. Her affected brother had similar features. Table S1 . The DOCK3 variant was present in 53 of 54 (98.2%) reads in the proband, inherited from the unaffected heterozygous mother and was absent in the unaffected father. The alteration is predicted to introduce a premature stop codon within exon 6, which will result in a truncated transcript expected to undergo nonsense mediated mRNA decay. No other candidate alterations were identified in DOCK3 or in any other genes. As the previously identified paternally inherited deletion of 3p21.2 included DOCK3, it was concluded that the proband was hemizygous for the c.382C>G (p.Gln128*) alteration but appeared to be homozygous due to allele drop out. The c.382C>G (p.Gln128*) DOCK3 alteration was confirmed in the proband, her mother, and her affected brother using automated fluorescence dideoxy sequencing ( Figure 1A,B) .
Because the affected brother carried the familial 3p21.1 deletion, he was determined to be hemizygous for the c.382C>G (p.Gln128*) nonsense variant in DOCK3. and NR2D (encoded by GRIN2D) subunits. 15, 18 Dock3 has been shown to bind to the C-terminal domain of NR2B in neural tissues in mice, thereby exerting a neuroprotective effect via NMDA-induced NR2B degradation in mouse retina. 15 in vitro and in vivo data suggest that the interaction between Dock3 and NR2D subunits may protect from glutamate excitotoxicity by reducing surface expression of NR2D. 18 In previous studies, pathogenic variants in GRIN2B and GRIN2D have been identified in patients with neurodevelopmental disorders, including intellectual disability, epileptic encephalopathies, and autism spectrum disorder.
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Mice homozygous for disruption of Dock3 exhibit gait abnormalities and ataxia, limb weakness, and impairment in learning ability. Other members of the DOCK180 family have been implicated in human disease. Biallelic loss-of-function variants in DOCK7 have been described as a rare cause of epileptic encephalopathy in 2 families with early-onset intractable epilepsy, dysmorphic facial features, cortical visual impairment, and intellectual disability. 22 The identification of a family with complete loss of DOCK3 function further supports the role of this family of proteins in the pathogenesis of neurodevelopmental disorders.
The current family also highlights the utility of combining WES with chromosomal microarray analysis. The proband had initially been found to carry a small 3p21.2 deletion, inherited from her unaffected
